Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC149621 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.981 | High Similarity | NPC215597 |
0.6818 | Remote Similarity | NPC262236 |
0.6789 | Remote Similarity | NPC76536 |
0.6667 | Remote Similarity | NPC277608 |
0.6381 | Remote Similarity | NPC100312 |
0.6381 | Remote Similarity | NPC204104 |
0.6321 | Remote Similarity | NPC270637 |
0.6032 | Remote Similarity | NPC180417 |
0.5952 | Remote Similarity | NPC20249 |
0.5886 | Remote Similarity | NPC267928 |
0.5787 | Remote Similarity | NPC19872 |
0.5774 | Remote Similarity | NPC219963 |
0.5774 | Remote Similarity | NPC161887 |
0.5774 | Remote Similarity | NPC266551 |
0.5767 | Remote Similarity | NPC476518 |
0.5732 | Remote Similarity | NPC121658 |
0.5732 | Remote Similarity | NPC14651 |
0.5714 | Remote Similarity | NPC226202 |
0.5697 | Remote Similarity | NPC111624 |
0.5691 | Remote Similarity | NPC245816 |
0.5691 | Remote Similarity | NPC476138 |
0.5669 | Remote Similarity | NPC317307 |
0.5616 | Remote Similarity | NPC470140 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC149621 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6261 | Remote Similarity | NPD8835 | Approved |
0.605 | Remote Similarity | NPD9101 | Discontinued |
0.5882 | Remote Similarity | NPD3576 | Approved |
0.5882 | Remote Similarity | NPD3575 | Approved |
0.5864 | Remote Similarity | NPD565 | Phase 2 |
0.5772 | Remote Similarity | NPD9472 | Phase 3 |
0.5755 | Remote Similarity | NPD2225 | Clinical (unspecified phase) |
0.5705 | Remote Similarity | NPD9596 | Approved |
0.5705 | Remote Similarity | NPD9595 | Approved |
0.566 | Remote Similarity | NPD9574 | Clinical (unspecified phase) |
0.5634 | Remote Similarity | NPD1807 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD1033 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD1034 | Phase 3 |
PubChem CID   | 520098 |
ChEMBL   | CHEMBL94514 |
ZINC   |
Molecular Weight:   | 166.11 |
ALogP:   | -0.1551 |
MLogP:   | 2.12 |
XLogP:   | 1.781 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 35.01 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 1 |
# Heavy Atoms:   | 12 |